NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares at an anticipated offering price in the range of $5 ...

Nov. 20, 2024 — Wings may be the obvious choice when studying the connection between dinosaurs and birds, but a pair of paleontologists prefer drumsticks. That part of the leg, they say, is ...

Prime Minister Narendra Modi on Sunday inaugurated a 13-km section of the Delhi-Meerut Regional Rapid Transit System (RRTS) ...

Jammu:�Police have arrested a government employee for allegedly opening fire at a BJP youth leader following an altercation ...

Anbio Biotechnology seeks IPO funding to expand in the IVD market. Discover why NNNN stock’s potential is tempered by ...

Anbio Biotechnology (NNNN), a developer of in vitro diagnostics, has filed to raise around $9M through a U.S. initial public offering. Read more here.

Anbio Biotechnology filed for a 1.6 million-share initial public offering with the Securities and Exchange Commission. The company said Tuesday it expects the IPO to price between $5 and $6 per share, ...

JAIPUR: Two more persons who suffered critical burn injuries in the tanker fire incident in Jaipur last Friday succumbed ...